Clinical Trials Logo

Filter by:
NCT ID: NCT05225805 Completed - Cystic Fibrosis Clinical Trials

Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis

Start date: March 1, 2022
Phase: Phase 1
Study type: Interventional

This study is intended to assess the pharmacokinetic (PK) and safety of a single dose of IV and oral formulations of lefamulin in adults with cystic fibrosis (CF).

NCT ID: NCT05225506 Completed - Parkinson Disease Clinical Trials

Support + High Intensity Functional Training for Parkinson's

SHIFT-PD
Start date: February 21, 2022
Phase: N/A
Study type: Interventional

Parkinson's is the fastest growing neurological disorder in the world. With more people living with Parkinson's than ever before, there is an urgent need for interventions that improve health and reduce disability. High intensity exercise has shown to be superior to other forms of exercise in that it can slow symptom progression. High intensity exercise also reduces the risk of cardiovascular events. This is pertinent considering one in five people with Parkinson's will die from cardiovascular disease. While Parkinson's specific exercise programs across the U.S. continue to increase, there are still many communities with limited to no access, including Fort Smith, Arkansas. Here, there are no expert level centers within 100 miles and not a single community-based exercise program. This research will offer a community and group-based exercise program for participants with Parkinson's and their care partners.

NCT ID: NCT05225389 Completed - Alzheimer Disease Clinical Trials

Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of CT1812 in Healthy Adult Male Subjects

COG0108
Start date: December 31, 2021
Phase: Phase 1
Study type: Interventional

Open-label, single-dose study to assess the absorption, metabolism, excretion and mass balance of [C14] CT1812

NCT ID: NCT05225298 Completed - Clinical trials for End-stage Renal Disease

SARS-COV-2 Screening in Dialysis Facilities

Start date: February 6, 2023
Phase: N/A
Study type: Interventional

Patients receiving dialysis are one of the highest risk groups for serious illness with SARS-CoV-2 infection. In addition to the inherent risks of travel to and dialysis within indoor facilities, patients receiving dialysis are more likely to be older, non-white, from disadvantaged backgrounds, and have impaired immune responses to viral infections and vaccinations. Universal testing offered at hemodialysis facilities could shield this vulnerable population from exposure, enable early identification and treatment for those affected, and reduce transmission to other patients and family members. In this pragmatic cluster randomized controlled trial as part of NIH RADx-UP Consortium, we will randomize 62 US Renal Care facilities with an estimated 2480 patients to static versus dynamic universal screening testing strategies. Static universal screening will involve offering patients SARS-CoV-2 screening tests every two weeks; the dynamic universal screening strategy will vary the frequency of testing from once every week to once every four weeks, depending on community COVID-19 case rates. We hypothesize that patients dialyzing at facilities randomized to a dynamic testing frequency responsive to community case rates will have higher test acceptability (primary outcome), experience lower rates of COVID-19 death and hospitalization, and report better experience-of-care metrics.

NCT ID: NCT05225220 Completed - Clinical trials for Cognitive Dysfunction

Multimodal Investigation of Post COVID-19 in Females

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of transcutaneous vagus nerve stimulation (t-VNS) on Long Covid symptoms in females and to identify factors influencing susceptibility and recovery-particularly in the cognitive domain, as over 80% of long-haulers experience "brain fog".

NCT ID: NCT05225025 Completed - Clinical trials for Postpartum Depression

A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital

Start date: July 5, 2021
Phase: N/A
Study type: Interventional

This study is a pilot, single-center, randomized controlled trial. It will 1. determine feasibility and acceptability of an evidence-based intervention for prevention of postpartum depression with antepartum patients on a high-risk obstetric unit, 2. determine what adaptations may be needed for an inpatient population 3. determine what retention strategies are most successful and acceptable for this patient population 4. estimate the effect size of an intervention for in-hospital distress, anxiety and depression 5. estimate the effect size of an intervention to reduce the risk of a post-partum depression diagnosis or depressive symptoms.

NCT ID: NCT05224843 Completed - Elder Abuse Clinical Trials

Feasibility of VOICES Elder Abuse Intervention in Primary Care Setting (VOICES-PC Feasibility)

VOICES-PC
Start date: December 17, 2021
Phase: Phase 1
Study type: Interventional

To test an interactive intervention to screen for Elder Abuse and Mistreatment (EM) in the Primary Care (PC) setting to promote self-identification and self-disclosure of EM.

NCT ID: NCT05224544 Completed - Clinical trials for Urinary Incontinence

Intermittent Catheterisation on the Bladder Mucosa of Healthy Volunteers With a Micro Hole Zone Catheter

CP341
Start date: January 31, 2022
Phase: N/A
Study type: Interventional

This investigation is a randomized, single-blinded, parallel, single-center investigation. In total, up to 50 subjects (40 completers) will be included and each subject will have two test visits overseen by the Principal Investigator (PI), or designee. Each subject will be enrolled in the investigation, which can be up to 3 days (if Day 0 and Day 1 are not on same day). The subjects will be randomly assigned to test either the test product or the comparator product, with at least 20 subjects assigned to each product.

NCT ID: NCT05224427 Completed - Test Anxiety Clinical Trials

A Pilot Study of Reducing Test-Anxiety in a Cohort of Underrepresented in Medicine MCAT Students Using Near-Peer Coaching

Start date: August 1, 2019
Phase:
Study type: Observational

We elected to establish a pilot near-peer coaching program for URM students enrolled at the Medical College of Wisconsin MCAT program. We quantified baseline and specific time point test-anxieties using the validated Westside test anxiety scale. We asked about MCAT concerns and program impressions via a free response section and analyzed results with inductive analysis.

NCT ID: NCT05224050 Completed - Tobacco Smoking Clinical Trials

Heart Rate Variability Biofeedback for Smoking Cessation Treatment

HRVB-SCT
Start date: November 29, 2021
Phase: Phase 2
Study type: Interventional

The purpose of the study is to conduct an open trial examining the feasibility and acceptability of an adapted heart rate variability biofeedback and smoking cessation treatment that was using a primarily virtual remote intervention.